| 标题 |
Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Oncology 作者:Robert L. Coleman; Mark F. Brady; Thomas J. Herzog; Paul Sabbatini; Deborah K. Armstrong; et al 出版日期:2017-04-21 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)